Prevalence and risk factors for isolated untreated systolic hypertension in rural Mongolian and Han populations

Acta Cardiologica

Volumn 63, Issue 3, 2008, Pages 389-393

  Li, Jiajin ^a   Xu, Changlu ^a   Sun, Zhaoqing ^a   Zheng, Liqiang ^a   Li, Jue ^b   Zhang, Dayi ^c   Zhang, Xingang ^a   Liu, Shuangshuang ^a   Zhao, Fenfen ^a   Hu, Dayi ^b   Sun, Yingxian ^a,d  

^a Shengjing Hospital of China Medical University   (China)

^b TONGJI UNIVERSITY   (China)

^c General Hospital Attached to Fuxin Mining Group   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

Author keywords

China; Isolated systolic hypertension; Prevalence; Risk factors; Rural population

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHINA; ETHNIC GROUP; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; ISOLATED SYSTOLIC HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONGOLOID RACE; PREVALENCE; RISK FACTOR; RURAL POPULATION; SALT INTAKE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD PRESSURE; CHINA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MONGOLIA; MULTICENTER STUDIES AS TOPIC; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; RURAL POPULATION; SYSTOLE;

EID: 46449095230     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.3.1020317     Document Type: Article

References (17)

1. Murray CJ, Lopez AD. Global pattern of cause of death and burden of disease in 1990, with projections to 2020 investing in health research and development. Report of the ad hoc Committee on Health Research Relation to Future Intervention Options. Geneva: World Health Organization, 1996.
2. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, He J, InterA-SIA Collaborative Group: The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002; 40: 920-7.
3. Aram V. Chobanian, George L. Bakris, Henry R. Black and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
4. Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY, Shyu YK. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005; 23: 1355-60.
5. National High Blood Pressure Education Program. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-46.
6. Huang J, Wildman RP, Gu D, Muntner P, Su S, He J. Prevalence of isolated systolic and isolated diastolic hypertension subtypes in China. Am J Hypertens 2004; 17: 955-62.
7. Kim JA, Kim SM, Choi YS, Yoon D, Lee JS, Park HS, Kim HA, Lee J, Oh HJ, Choi KM. The prevalence and risk factors associated with isolated untreated systolic hypertension in Korea: the Korean National Health and Nutrition Survey 2001. J Hum Hypertens 2007; 21: 107-13.
8. Joffres MR, Hamet P, MacLean DR, L'italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001; 14: 1099-105.
9. Qureshi AI, Suri MF, Mohammad Y, Guterman LR, Hopkins LN. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the national health and nutrition survey. Stroke 2002; 33: 2781-8.
10. Petrovitch H, Curb JD, Bloom-Marcus E. Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke 1995; 26: 25-9.
11. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension: the Framingham Study. Circulation 1980; 61: 1179-82.
12. Colandrea MA, Friedman GD, Nichaman MZ, Lynd CN. Systolic hypertension in the elderly. Circulation 1970; 41: 239-45.
13. Curb JD, Borhani NO, Entwisle G, Tung B, Kass E, Schnaper H, Williams W, Berman R. Isolated systolic hypertension in 14 communities. Am J Epidemiol 1985; 121: 362-70.
14. Shekelle RB, Ostfeld AM, Klawans HL Jr. Hypertension and risk of stroke in an elderly population. Stroke 1974; 5: 71-5.
15. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-64.
16. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64.
17. Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998; 16: 1823-9.